The 2026 Verizon Data Breach Investigations Report reveals that phishing, credential theft, and malicious extensions increasingly operate within the browser itself, exposing a critical security gap in modern attack tactics.
Browser-based attacks have become a primary vector for threat actors, according to the latest DBIR findings. Phishing campaigns, shadow AI deployment, malicious browser extensions, and credential harvesting now frequently target users at the application layer rather than the network perimeter.
The report highlights how attackers exploit the browser's privileged position in user workflows. Extensions with legitimate-appearing permissions grant attackers access to passwords, session tokens, and sensitive data. Phishing attacks delivered through browser windows bypass traditional email security measures.
Credential theft remains the leading attack method, with browsers serving as the harvesting ground. Shadow AI—unauthorized AI tools running in browser contexts—presents an emerging threat for data exfiltration and system manipulation.
The findings underscore that endpoint security must now extend beyond traditional antivirus to include browser-layer defenses. Organizations should prioritize extension governance, user authentication practices, and browser isolation technologies to counter these evolving threats.
A race condition vulnerability in the Linux kernel's XFS filesystem allows local attackers to overwrite protected files and gain root privileges. The flaw, tracked as CVE-2026-64600, has remained unpatched for nine years.
Intensified enforcement against online scam operations in Cambodia is displacing criminal networks to Sri Lanka, where authorities have arrested over 1,000 people in 2026.
Offensive cybersecurity researchers report that safety guardrails from OpenAI and Anthropic are restricting their ability to find vulnerabilities and develop security tools. The limitations are creating friction for legitimate security work.
European drug traffickers are leveraging AI-boosted chemical synthesis to create designer drug precursors that circumvent existing product blacklists, according to an EU agency warning.